查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012889

細菌學檢測市場：2026-2032年全球市場預測（按技術、檢體類型、目標微生物類型、應用和最終用戶分類）

Bacteriological Testing Market by Technology, Sample Type, Organism Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，細菌檢測市場價值將達到 136.3 億美元，到 2026 年將成長至 148.3 億美元，到 2032 年將達到 291.1 億美元，複合年成長率為 11.44%。

主要市場統計數據
基準年 2025 136.3億美元
預計年份：2026年 148.3億美元
預測年份 2032 291.1億美元
複合年成長率 (%) 11.44%

權威概述了細菌學檢測如何在複雜的操作環境中支援公共衛生保護、工業品質和臨床決策。

細菌學檢測處於公共衛生保護、工業品質保證和臨床決策的交匯點。有效的檢測策略能夠降低感染傳播風險，保護供應鏈，並支持醫療保健、食品生產、藥品製造、供水事業和環境監測項目等領域的合規性。隨著微生物調查方法的進步，相關人員期望獲得更短的周轉時間、更高的分析靈敏度和更清晰的解讀框架，以便快速回應。因此，實驗室和服務提供者正在努力平衡技術投資與嚴格的品質體系，以滿足日益成長的對可操作結果的需求。

技術融合、監管加強和營運韌性如何將細菌學檢測從簡單的診斷最後手段轉變為策略性風險管理能力。

隨著技術、監管和市場因素的融合，細菌學檢測領域正在迅速變化，重塑各組織檢測和管理微生物風險的方式。分子診斷技術的進步，包括更快的即時擴增和更便捷的定序，使得病原體的早期和特異性檢測成為可能。同時，自動化培養系統和改良的選擇性培養基正在減輕常規監測的工作量並提高檢測結果的可重複性。這些互補的能力正在推動檢測方式從單純的確認性檢測轉向預測性和預防性應用，其中數據能夠指導上游管理。

分析近期關稅變化如何重塑美國細菌檢測相關人員的採購、供應商策略和業務永續營運。

2025年美國關稅政策的變化正在影響細菌檢測中使用的實驗室設備、耗材和試劑的籌資策略、全球供應鏈和成本結構。進口關稅和分類的調整可能會影響自動化分析儀、選擇性培養基、分子檢測套組和定序耗材的到貨成本，促使採購團隊重新評估總擁有成本 (TCO) 和供應商多元化策略。在許多情況下，實驗室經理和採購主管正在採用多供應商籌資策略並增加庫存緩衝，以確保在關稅相關的價格波動劇烈時期檢測業務的連續性。

透過對應用程式、技術、最終用戶、檢體類型和病原體分類進行細分，確定不同的優先級，從而進行有針對性的決策。

基於細分市場的洞察揭示了不同應用領域、技術類型、最終用戶、檢體類型和微生物群落中，檢測優先順序、技術採用和服務交付模式存在顯著差異。在臨床診斷中，準確性和速度至關重要，快速分子診斷和免疫檢測是體外診斷和就地檢驗的首選方法，而實驗室自建檢測 (LDT) 則為特定病原體提供了柔軟性。環境監測需要在空氣品質採樣和土壤檢測技術的長期監測之間取得平衡，而食品和飲料安全計劃則側重於乳製品、肉類和即食食品基質，需要基於培養的確認和快速檢測來維護供應鏈的完整性。製藥和生物技術用戶需要對最終產品和原料進行驗證性檢驗，以符合嚴格的監管要求，而水質檢測則涵蓋飲用水和污水處理規程，以支持公共衛生和公共產業合規性。

詳細考察區域間優先事項和基礎設施的差異如何影響細菌學檢測的實施和能力建設。

區域趨勢正在影響全球細菌學檢測的優先順序、資金籌措和監管，每個地區市場都有其獨特的促進因素和部署模式。在美洲，相關人員優先考慮快速部署先進的診斷技術和一體化的檢查室網路，以支援公共衛生監測和成熟的私人醫療保健部門。檢查室現代化和對商業性診斷夥伴關係的投資十分普遍，法律規範也不斷完善，以應對新出現的微生物威脅。在歐洲、中東和非洲，監管協調、能力建設和基礎設施投資因地區而異，一些國家大力推動標準化品管的實施，而另一些國家則優先考慮基礎監測和培訓計畫。跨國合作和資金籌措舉措是擴大檢測覆蓋範圍和加強該地區應對感染疾病爆發準備工作的關鍵途徑。

對細菌檢測領域成功企業的競爭策略、夥伴關係模式和業務重點進行了深入分析。

對主要企業的分析突顯了成功企業為提升自身競爭力並在細菌檢測市場拓展業務規模而採取的策略方法。市場領導者通常將強大的研發能力與有針對性的夥伴關係關係相結合，以擴展其檢測產品組合併加快產品上市速度。許多企業也正在投資模組化實驗室平台和數位化報告解決方案，以促進不同終端用戶的互通性和便利部署。策略性收購仍是取得利基技術、拓展地域覆蓋範圍以及彌補定序、自動化或快速檢測方面能力缺口的常用手段。

領導者可以實施的具體且優先的建議，以增強檢查室的韌性，提高檢測性能，並確保符合監管規定。

產業領導企業可以採取明確可行的措施，增強檢查室的韌性，提升檢測能力，並使檢驗項目與策略目標保持一致。優先投資整合分子診斷和培養方法，以兼顧速度與確診的準確性；使用經過驗證的方案規範工作流程；簡化訓練；並減少變異性。加強與供應商的關係，並實施有關價格和供應連續性的合約保障措施，以降低關稅和全球物流中斷帶來的風險。同時，投資於數據互通性和數位化報告，將檢測結果轉化為及時有效的洞察，從而支持事件回應和持續改進。

採用混合方法研究設計，結合專家訪談、監管審查和技術映射，並以透明的解釋得出可操作的見解。

本分析的調查方法結合了定性和定量方法，以確保研究結果的穩健性和相關性。研究人員首先對實驗室經理、品管經理、採購負責人以及臨床、環境、食品安全、製藥和水處理領域的專家進行了訪談，以直接了解技術選擇方面的營運挑戰和發展趨勢。其次，研究人員查閱了監管指南、標準、同行評審文獻、行業期刊和公開的技術文件，以檢驗技術發展趨勢。

一份權威總結，重點闡述了綜合檢查方法、供應鏈韌性和人力資源準備對於持續營運安全的重要性。

總之，細菌學檢測正從單純的檢查室確認功能發展成為一項策略能力，為眾多領域的預防、合規和營運決策提供資訊支援。分子診斷、定序和自動化等技術的融合，與傳統培養方法相輔相成，實現了更快、更準確的檢測，同時也提高了對品質系統和人力資源能力的要求。關稅波動和採購壓力等政策和供應鏈趨勢，正迫使企業重新思考其採購、庫存策略和供應商關係，以確保業務永續營運並控制成本。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：細菌學檢測市場：依技術分類

  • 培養試驗
    • 自動化系統
    • 選擇性培養基
  • 免疫檢測
    • 酵素免疫分析法
    • 橫向流動化驗
  • 次世代定序
    • 目標序列
    • 全基因組定序
  • 聚合酵素鏈鎖反應
    • 數位PCR
    • 即時PCR
  • 快速檢測
    • 快速免疫檢測
    • 快速分子檢測

第9章：依檢體類型分類的細菌學檢測市場

  • 血液檢體
  • 食品樣品
  • 表面拭子
  • 尿液檢體
  • 水樣

第10章：以病原體類型分類的細菌學檢測市場

  • 細菌
  • 真菌
  • 寄生蟲
  • 病毒

第11章：細菌學檢測市場：依應用領域分類

  • 臨床診斷
    • 體外診斷
    • 實驗室開發的測試
    • 即時檢測
  • 環境監測
    • 空氣品質
    • 土壤取樣
  • 食品和飲料安全
    • 乳製品
    • 肉品
    • 即食食品
  • 製藥和生物技術
    • 最終產品
    • 原料
  • 水質檢測
    • 飲用水
    • 污水

第12章：細菌學檢測市場：依最終用戶分類

  • 環保組織
  • 食品加工廠
  • 醫院和診斷檢查室
  • 製藥公司
  • 水處理廠

第13章：細菌學檢測市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：細菌學檢測市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：細菌學檢測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國細菌學檢測市場

第17章：中國細菌檢測市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Merck KGaA
  • QIAGEN NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-437D45957E5D

The Bacteriological Testing Market was valued at USD 13.63 billion in 2025 and is projected to grow to USD 14.83 billion in 2026, with a CAGR of 11.44%, reaching USD 29.11 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.63 billion
Estimated Year [2026] USD 14.83 billion
Forecast Year [2032] USD 29.11 billion
CAGR (%) 11.44%

An authoritative overview of how bacteriological testing underpins health protection, industrial quality, and clinical decision-making in complex operational environments

Bacteriological testing stands at the intersection of public health protection, industrial quality assurance, and clinical decision-making. Effective testing strategies reduce outbreak risks, safeguard supply chains, and support regulatory compliance across healthcare, food production, pharmaceutical manufacturing, water utilities, and environmental monitoring programs. As microbial detection methodologies have advanced, stakeholders now expect faster turnaround, greater analytical sensitivity, and clearer interpretation frameworks to inform rapid action. Consequently, laboratories and testing providers are balancing investments in technology with rigorous quality systems to meet the rising demand for actionable results.

This introduction outlines core drivers shaping contemporary bacteriological testing: technological innovation, regulatory pressure, cross-sector risk management, and operational efficiency. Laboratories are integrating molecular and sequencing techniques into traditional culture-based workflows, while environmental and industrial users require scalable sampling programs that align with audit and certification needs. Against this evolving backdrop, decision-makers must prioritize capability gaps, workforce competency, and data governance to ensure testing remains a reliable pillar of prevention, diagnosis, and compliance efforts.

How technological convergence, regulatory tightening, and operational resilience are transforming bacteriological testing from diagnostic backstop to strategic risk management capability

The landscape of bacteriological testing has shifted rapidly due to converging technological, regulatory, and market forces that are reshaping how organizations detect and manage microbial risks. Advances in molecular diagnostics, including faster real-time amplification and more accessible sequencing, are enabling earlier and more specific detection of pathogens. At the same time, automated culture systems and improved selective media are reducing labor burden and enhancing reproducibility for routine surveillance. These complementary capabilities are catalyzing a transition from purely confirmatory testing to predictive and preventive applications where data informs upstream controls.

Regulatory requirements and accreditation expectations have tightened, prompting laboratory networks and industrial operators to invest in validated workflows and robust quality management systems. Environmental monitoring programs are moving from sporadic sampling to continuous, risk-based strategies that integrate air, soil, surface, and water testing. The industry is also responding to supply chain pressures and the need for resilient procurement models, with an emphasis on interoperability, digital reporting, and modular laboratory design. Taken together, these transformative shifts are elevating the role of bacteriological testing as a strategic function rather than a purely technical activity.

An analysis of how recent tariff shifts are reshaping procurement, supplier strategies, and operational continuity for bacteriological testing stakeholders in the United States

Tariff policy changes in the United States for 2025 are influencing procurement strategies, global supply chains, and cost structures for laboratory equipment, consumables, and reagents used in bacteriological testing. Import duties and classification updates can affect the landed cost of automated instruments, selective media, molecular assay kits, and sequencing consumables, prompting procurement teams to reassess total cost of ownership and vendor diversification. In many cases, laboratory directors and procurement managers are adopting multi-vendor sourcing strategies and increasing inventory buffers to maintain continuity of testing operations during periods of tariff-driven price volatility.

Beyond direct cost implications, tariffs are accelerating conversations around domestic manufacturing, strategic sourcing partnerships, and contractual protections that mitigate exposure to sudden tariff adjustments. Stakeholders are also revisiting instrument standardization and cross-compatibility to enable substitution of components when supply disruption occurs. As a result, organizations increasingly prioritize supplier risk assessments, contractual clauses that address tariff pass-through, and scenario planning to maintain compliance and uninterrupted testing services. These adaptive measures reflect a pragmatic response to policy-driven market dynamics while preserving the integrity of bacteriological testing programs.

Essential segmentation insights that illuminate differential priorities across applications, technologies, end users, sample types, and organism classifications for targeted decision making

Segmentation-driven insights reveal substantive differences in testing priorities, technology adoption, and service delivery models across application areas, technology types, end users, sample types, and organism groups. In clinical diagnostics, the focus centers on diagnostic accuracy and speed, with in vitro diagnostics and point of care testing prioritizing rapid molecular and immunoassay approaches, while laboratory developed tests provide flexibility for niche pathogens. Environmental monitoring requires a balance of air quality sampling and soil testing techniques that emphasize longitudinal surveillance, and food and beverage safety programs concentrate on dairy, meat, and ready-to-eat matrices that demand both culture confirmation and rapid detection to preserve supply chain integrity. Pharmaceutical and biotech users demand validated testing for final products and raw materials that align with stringent regulatory expectations, and water testing spans drinking water and wastewater protocols that support public health and utility compliance.

From a technology perspective, culture testing remains foundational for confirmation and susceptibility profiling, augmented by automated systems and selective media to improve throughput. Immunoassays are used widely for screening, with enzyme linked immunosorbent assays and lateral flow formats delivering different trade-offs between sensitivity and operational simplicity. Next generation sequencing provides deep characterization of organisms through targeted and whole genome approaches, enabling outbreak forensics and resistance tracking, while polymerase chain reaction modalities such as digital and real time PCR accelerate detection with quantitative precision. Rapid detection platforms, whether rapid immunoassay or rapid molecular, are enabling near-patient and on-site decision making. End users vary widely in capability and need: environmental agencies and water treatment plants often emphasize compliance and ambient surveillance, food processing facilities focus on contamination prevention and product release testing, hospitals and diagnostic laboratories prioritize clinical sensitivity and workflow integration, and pharmaceutical manufacturers require tightly validated processes. Sample type considerations-blood, food matrices, surface swabs, urine, and water-drive sampling protocols, pre-analytical handling, and method selection, while organism type classification among bacteria, fungi, parasites, and viruses informs assay design and interpretive criteria. Understanding these layered segmentations helps organizations tailor investments, optimize method selection, and design sampling programs that meet both operational and regulatory objectives.

A nuanced exploration of how distinct regional priorities and infrastructure differences are driving variation in bacteriological testing adoption and capability development

Regional dynamics are shaping how bacteriological testing is prioritized, funded, and regulated across the globe, with geographic markets exhibiting distinct drivers and adoption patterns. In the Americas, stakeholders emphasize rapid adoption of advanced diagnostics and integrated laboratory networks that support public health surveillance and a mature private healthcare sector. Investment in laboratory modernization and commercial diagnostic partnerships is common, and regulatory frameworks are continually refined to address emerging microbial threats. In Europe, the Middle East and Africa, regulatory harmonization, capacity building, and infrastructure investment vary considerably across jurisdictions, with some countries driving strong adoption of standardized quality management while others prioritize foundational surveillance and training programs. Cross-border collaboration and funding initiatives are important levers for expanding testing access and strengthening outbreak preparedness in the region.

The Asia-Pacific region demonstrates heterogeneous but fast-moving demand, characterized by rapid uptake of automated culture systems, molecular diagnostics, and large-scale environmental monitoring programs driven by industrial expansion and urbanization. Several markets in the region are investing heavily in local manufacturing and workforce training to support domestic testing capacity and reduce reliance on imports. Across all regions, interoperability of data systems, digital reporting, and harmonized validation practices are becoming central to cross-jurisdictional surveillance and incident response. These regional insights underscore the need for tailored deployment strategies that reflect local regulatory environments, resource constraints, and public health priorities.

Insightful analysis of competitive strategies, partnership models, and operational priorities that distinguish successful companies in bacteriological testing

Key company insights underscore strategic approaches that successful organizations use to compete and scale within the bacteriological testing landscape. Market leaders often combine strong R&D capabilities with targeted partnerships to broaden assay portfolios and accelerate time to market. Many also invest in modular laboratory platforms and digital reporting solutions that facilitate interoperability and ease of adoption across diverse end users. Strategic acquisitions remain a common pathway to acquiring niche technologies, expanding geographical footprints, and filling capability gaps in sequencing, automation, or rapid detection.

Service providers and contract laboratories differentiate through specialized application expertise, rapid turnaround times, and accredited quality systems that meet customer and regulator expectations. Suppliers that offer comprehensive technical support, training programs, and validated workflows tend to achieve deeper penetration into institutional customers such as hospitals, water utilities, and pharmaceutical manufacturers. Additionally, companies focusing on localized manufacturing and supply chain resilience are gaining traction where tariff or logistical volatility threatens continuity. Collectively, these competitive behaviors reflect a market where technology breadth, regulatory alignment, and customer-centric service models provide meaningful advantage.

Concrete and prioritized recommendations that leaders can implement to fortify laboratory resilience, improve detection performance, and ensure regulatory readiness

Industry leaders can take clear, actionable steps to strengthen laboratory resilience, improve detection capabilities, and align testing programs with strategic goals. Prioritize investments that integrate molecular and culture-based methods to balance speed with confirmatory certainty, and standardize workflows with validated protocols to streamline training and reduce variability. Strengthening supplier relationships and implementing contractual safeguards around pricing and supply continuity will mitigate disruption risks related to tariffs and global logistics. In parallel, invest in data interoperability and digital reporting to transform test results into timely intelligence that supports incident response and continuous improvement.

Workforce development is equally important; targeted training, cross-training, and competency assessments ensure that personnel can operate advanced platforms and interpret complex molecular or sequencing outputs. Implementing risk-based sampling frameworks will optimize resource allocation by focusing testing on high-impact matrices and critical control points. Finally, maintain active engagement with regulators and accreditation bodies to anticipate changes and position testing programs proactively for compliance and public health partnerships. These strategic actions enable organizations to convert testing capability into demonstrable operational and reputational value.

A transparent explanation of the mixed methods research design combining expert interviews, regulatory review, and technology mapping to derive actionable insights

The research methodology underpinning this analysis blends qualitative and quantitative approaches to ensure robustness and relevance. Primary interviews were conducted with laboratory directors, quality managers, procurement officers, and subject matter experts across clinical, environmental, food safety, pharmaceutical, and water sectors to capture firsthand operational challenges and technology preferences. Secondary research included a review of regulatory guidance, standards, peer-reviewed literature, trade publications, and publicly available technical materials to validate trends and technological developments.

Analytical frameworks incorporated technology adoption mapping, segmentation analysis by application and end user, and supplier capability assessments to synthesize cross-cutting insights. Triangulation of data sources and iterative validation with industry practitioners were used to minimize bias and enhance practical applicability. Throughout the process, care was taken to ensure that findings reflect operational realities, sectoral nuances, and the latest methodological advances in bacteriological testing without relying on speculative forecasting models.

A decisive wrap-up highlighting the strategic importance of integrated testing approaches, supply resilience, and workforce readiness for sustained operational security

In conclusion, bacteriological testing is evolving from a confirmatory laboratory function into a strategic capability that informs prevention, compliance, and operational decision making across multiple sectors. Technology convergence-where molecular diagnostics, sequencing, and automation complement traditional culture methods-is enabling faster, more precise detection while also raising expectations around quality systems and workforce competency. Policy and supply chain dynamics, including tariff shifts and procurement pressures, are prompting organizations to rethink sourcing, inventory strategies, and supplier relationships to protect continuity and manage costs.

To remain effective in this changing environment, stakeholders must adopt integrated testing strategies that align method selection with application needs, invest in interoperability and data-driven workflows, and maintain proactive engagement with regulators and industry partners. By doing so, organizations will not only improve their capacity to detect and respond to microbial risks but also transform testing into a measurable contributor to operational resilience and public health protection.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bacteriological Testing Market, by Technology

  • 8.1. Culture Testing
    • 8.1.1. Automated Systems
    • 8.1.2. Selective Media
  • 8.2. Immunoassay
    • 8.2.1. Enzyme Linked Immunosorbent Assay
    • 8.2.2. Lateral Flow Assay
  • 8.3. Next Generation Sequencing
    • 8.3.1. Targeted Sequencing
    • 8.3.2. Whole Genome Sequencing
  • 8.4. Polymerase Chain Reaction
    • 8.4.1. Digital PCR
    • 8.4.2. Real Time PCR
  • 8.5. Rapid Detection
    • 8.5.1. Rapid Immunoassay
    • 8.5.2. Rapid Molecular

9. Bacteriological Testing Market, by Sample Type

  • 9.1. Blood Samples
  • 9.2. Food Samples
  • 9.3. Surface Swabs
  • 9.4. Urine Samples
  • 9.5. Water Samples

10. Bacteriological Testing Market, by Organism Type

  • 10.1. Bacteria
  • 10.2. Fungi
  • 10.3. Parasites
  • 10.4. Viruses

11. Bacteriological Testing Market, by Application

  • 11.1. Clinical Diagnostics
    • 11.1.1. In Vitro Diagnostics
    • 11.1.2. Laboratory Developed Tests
    • 11.1.3. Point Of Care Testing
  • 11.2. Environmental Monitoring
    • 11.2.1. Air Quality
    • 11.2.2. Soil Sampling
  • 11.3. Food And Beverage Safety
    • 11.3.1. Dairy Products
    • 11.3.2. Meat Products
    • 11.3.3. Ready To Eat Products
  • 11.4. Pharmaceutical And Biotech
    • 11.4.1. Final Products
    • 11.4.2. Raw Materials
  • 11.5. Water Testing
    • 11.5.1. Drinking Water
    • 11.5.2. Wastewater

12. Bacteriological Testing Market, by End User

  • 12.1. Environmental Agencies
  • 12.2. Food Processing Facilities
  • 12.3. Hospitals And Diagnostic Laboratories
  • 12.4. Pharmaceutical Manufacturers
  • 12.5. Water Treatment Plants

13. Bacteriological Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bacteriological Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bacteriological Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Bacteriological Testing Market

17. China Bacteriological Testing Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Becton, Dickinson and Company
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. bioMerieux SA
  • 18.9. Danaher Corporation
  • 18.10. F. Hoffmann-La Roche AG
  • 18.11. Merck KGaA
  • 18.12. QIAGEN N.V.
  • 18.13. Siemens Healthineers AG
  • 18.14. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BACTERIOLOGICAL TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SELECTIVE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LATERAL FLOW ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BLOOD SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SURFACE SWABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY URINE SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY LABORATORY DEVELOPED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY SOIL SAMPLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY MEAT PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY READY TO EAT PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FINAL PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY RAW MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY DRINKING WATER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WASTEWATER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD PROCESSING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TREATMENT PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL BACTERIOLOGICAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY RAPID DETECTION, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY ORGANISM TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY FOOD AND BEVERAGE SAFETY, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY WATER TESTING, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN BACTERIOLOGICAL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. GCC BACTERIOLOGICAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. GCC BACTERIOLOGICAL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. GCC BACTERIOLOGICAL TESTING MARKET SIZE, BY CULTURE TESTING, 2018-2032 (USD MILLION)
  • TABLE 304. GCC BACTERIOLOGICAL TESTING MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
  • TABLE 305. GCC BACTERIOLOGICAL TE